CVRS News and Press, Corindus Vascular Robotics Inc. (DE) From 03/05/19

Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it will release fourth quarter and full year 2018 financial and business results on Tuesday, March 12, 2019 after the close of the U.S. financial markets. Mark...

Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, will present at the 39 th Annual Cowen Health Care Conference as follows: The presentation will be webcast...

Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American:CVRS), a leading developer of precision vascular robotics, today announced the execution of a private placement transaction with a large institutional investor pursuant to which it ...

Expansion of CorPath GRX into neurovascular intervention could mark first step in revolutionizing stroke treatment Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotic...